Publication Number
WO/2024/176130
Publication Date
29.08.2024
International Application No.
PCT/IB2024/051654
International Filing Date
21.02.2024
Title
[English]
TEAD- AND HER2-INHIBITOR COMBINATIONS FOR TREATING CANCER
[French]
COMBINAISONS D'INHIBITEURS DE TEAD ET DE HER2 POUR LE TRAITEMENT DU CANCER
Applicants **
NOVARTIS AG
Lichtstrasse 35
4056 Basel, CH
Inventors **
BALTSCHUKAT, Sabrina
Novartis Pharma AG
Lichtstrasse 35
4056 Basel, CH
CHAPEAU, Emilie
Novartis Pharma AG
Lichtstrasse 35
4056 Basel, CH
FARIS, Jason
Novartis Institutes for BioMedical Research, Inc.
250 Massachusetts Avenue
Cambridge, Massachusetts 02139, US
JAAKS, Patricia
Novartis Pharma AG
Lichtstrasse 35
4056 Basel, CH
Priority Data
63/486,504
23.02.2023
US
Application details
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Abstract
[English]
The invention relates to a pharmaceutical combination comprising a TEAD inhibitor in combination with a HER2 inhibitor, as well as methods of treating cancers using said combination.
[French]
L'invention concerne une combinaison pharmaceutique comprenant un inhibiteur de TEAD en combinaison avec un inhibiteur de HER2, ainsi que des méthodes de traitement de cancers à l'aide de ladite combinaison.